USS Investment Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.74M | Buy |
19,068
+2,971
| +18% | +$577K | 0.01% | 415 |
|
|
2025
Q4 | $2.79M | Buy |
16,097
+110
| +0.7% | +$20K | 0.01% | 456 |
|
|
2025
Q3 | $3.05M | Hold |
15,987
| – | – | 0.01% | 451 |
|
|
2025
Q2 | $2.87M | Sell |
15,987
-75
| -0.5% | -$13K | 0.02% | 456 |
|
|
2025
Q1 | $2.72M | Hold |
16,062
| – | – | 0.02% | 453 |
|
|
2024
Q4 | $2.42M | Sell |
16,062
-5,986
| -27% | -$931K | 0.02% | 493 |
|
|
2024
Q3 | $3.42M | Buy |
22,048
+66
| +0.3% | +$9.86K | 0.02% | 450 |
|
|
2024
Q2 | $3.01M | Hold |
21,982
| – | – | 0.02% | 451 |
|
|
2024
Q1 | $2.93M | Buy |
21,982
+1,332
| +6% | +$173K | 0.02% | 456 |
|
|
2023
Q4 | $2.85M | Sell |
20,650
-5,974
| -22% | -$785K | 0.03% | 473 |
|
|
2023
Q3 | $3.24M | Buy |
26,624
+391
| +1% | +$52.1K | 0.04% | 443 |
|
|
2023
Q2 | $3.69M | Hold |
26,233
| – | – | 0.04% | 419 |
|
|
2023
Q1 | $3.71M | Hold |
26,233
| – | – | 0.05% | 405 |
|
|
2022
Q4 | $4.1M | Sell |
26,233
-24,900
| -49% | -$3.58M | 0.06% | 371 |
|
|
2022
Q3 | $6.28M | Sell |
51,133
-9,075
| -15% | -$1.2M | 0.09% | 242 |
|
|
2022
Q2 | $8.01M | Sell |
60,208
-2,838
| -5% | -$387K | 0.08% | 261 |
|
|
2022
Q1 | $8.63M | Buy |
63,046
+1,773
| +3% | +$247K | 0.07% | 300 |
|
|
2021
Q4 | $10.6M | Hold |
61,273
| – | – | 0.08% | 251 |
|
|
2021
Q3 | $8.9M | Buy |
61,273
+21,078
| +52% | +$3.08M | 0.08% | 273 |
|
|
2021
Q2 | $5.3M | Hold |
40,195
| – | – | 0.04% | 250 |
|
|
2021
Q1 | $5.16M | Hold |
40,195
| – | – | 0.04% | 240 |
|
|
2020
Q4 | $4.79M | Hold |
40,195
| – | – | 0.04% | 233 |
|
|
2020
Q3 | $4.6M | Hold |
40,195
| – | – | 0.04% | 218 |
|
|
2020
Q2 | $4.58M | Sell |
40,195
-59,505
| -60% | -$6.31M | 0.05% | 211 |
|
|
2020
Q1 | $8.01M | Hold |
99,700
| – | – | 0.11% | 132 |
|
|
2019
Q4 | $10.6M | Sell |
99,700
-14,500
| -13% | -$1.51M | 0.1% | 121 |
|
|
2019
Q3 | $12.2M | Hold |
114,200
| – | – | 0.13% | 97 |
|
|
2019
Q2 | $11.6M | Buy |
114,200
+10,900
| +11% | +$1.05M | 0.12% | 94 |
|
|
2019
Q1 | $9.29M | Hold |
103,300
| – | – | 0.1% | 101 |
|
|
2018
Q4 | $8.6M | Buy |
103,300
+3,000
| +3% | +$281K | 0.11% | 97 |
|
|
2018
Q3 | $10.8M | Hold |
100,300
| – | – | 0.11% | 90 |
|
|
2018
Q2 | $11M | Hold |
100,300
| – | – | 0.12% | 77 |
|
|
2018
Q1 | $10.2M | Buy |
+100,300
| New | +$10.3M | 0.11% | 91 |
|
|
2017
Q2 | – | Sell |
-227,500
| Closed | -$22.3M | – | 146 |
|
|
2017
Q1 | $22.3M | Hold |
227,500
| – | – | 0.31% | 80 |
|
|
2016
Q4 | $20.9M | Buy |
+227,500
| New | +$19.6M | 0.32% | 74 |
|
Other funds holding DGX
VCM
VPM
EIG
USS Investment Management's DGX Position: Q1 2026 in Review
USS Investment Management increased its Quest Diagnostics (DGX) stake by 18% in Q1 2026, buying an estimated $577K and bringing the position to 19,068 shares worth $3.74M. The position accounts for 0.01% of the portfolio, ranked #415.
USS Investment Management first reported a position in DGX in Q4 2016 and has held it in 35 quarters since. The position peaked at $22.3M in Q1 2017. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.
- USS Investment Management held 19,068 shares of Quest Diagnostics worth $3.74M as of Q1 2026.
- USS Investment Management bought 2,971 Quest Diagnostics shares in Q1 2026, an estimated $577K.
- Quest Diagnostics made up 0.01% of USS Investment Management's portfolio in Q1 2026, its #415 holding.
- USS Investment Management first reported a position in Quest Diagnostics in Q4 2016 and has held it in 35 quarters since.
- USS Investment Management's Quest Diagnostics position peaked at $22.3M in Q1 2017.
- 1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.
Based on USS Investment Management's 13F filing for Q1 2026, filed 24 Apr 2026.